Medspartner Helps Australians Access Affordable Cancer / Rare Disease Medicines Not Covered by PBS

SYDNEY - July 7, 2025 - PRLog -- As Australian cancer and rare disease patients continue to face high out-of-pocket costs for medications not covered by the PBS (Pharmaceutical Benefits Scheme), MedsPartner is offering new hope. This global access platform helps Australians legally and safely import life-extending treatments from certified international manufacturers, at a fraction of the local price.

"Too many Australians are left waiting or paying thousands each month for medicines that could change their lives," says Aayyush Goyal, Founder of Medspartner. "We support patients through every step—from sourcing safe alternatives to handling customs and delivery."

Why It Matters

Medspartner provides a bridge for patients when:

• A prescribed drug isn't PBS-listed or stocked in Australia
  
  
• Costs through private pharmacies are unaffordable
  
  
• Urgent access is needed for rare cancers or advanced disease
  
  

How Medspartner Works

Australians can legally import up to three months' supply of prescribed medicines for personal use under the Therapeutic Goods Administration's (TGA) Personal Importation Scheme. Medspartner helps patients by:

• Connecting them to FDA/EMA-certified manufacturers who stock affordable versions
• Offering transparent pricing and quotes
• Handling prescriptions, customs clearance, and delivery
• Encouraging collaboration with the patient's treating doctor
• Providing end-to-end support
• Ensuring quality and safety

Advocacy & Community

Medspartner also supports advocacy through its growing network of patients, clinicians, and caregivers across Australia. From family caregivers to survivors, all voices are welcome.

For more information or to speak with a patient guide, visit www.medspartner.com.